Masayasu Sekiguchi

435 citations
8 papers · 356 indexed · h-index 8
Topics
Antibiotics Pharmacokinetics and Efficacy (6 papers)Orthopedic Infections and Treatments (3 papers)bioluminescence and chemiluminescence research (2 papers)

In The Last Decade

Masayasu Sekiguchi

8 papers receiving 331 citations

Peers

Masayasu Sekiguchi
Comparison fields: 5 of 84
  • Pharmacology 167
  • Molecular Biology 133
  • Oncology 90
  • Epidemiology 40
  • Psychiatry and Mental health 37
Replace Xavier Fonrose with:
Xavier Fonrose France
Bernhard Burian Austria
Lee Cc Taiwan
D Pharm United States
Amel Chaabane Tunisia
Virginie Gualano France
Milton M. Cahn United States
Deborah Johnson United Kingdom
Stanley I. Cullen United States
Simone von Bonin Germany
Masayasu Sekiguchi relative to Xavier Fonrose France Xavier Fonrose's profile →
Citations per field
00.5×1.5×2.0×
Xavier Fonrose · 1×
Citations per year

Countries citing papers authored by Masayasu Sekiguchi

Since Specialization
Citations

This map shows the geographic impact of Masayasu Sekiguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayasu Sekiguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayasu Sekiguchi more than expected).

Fields of papers citing papers by Masayasu Sekiguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayasu Sekiguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayasu Sekiguchi. The network helps show where Masayasu Sekiguchi may publish in the future.

Co-authorship network of co-authors of Masayasu Sekiguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Masayasu Sekiguchi. A scholar is included among the top collaborators of Masayasu Sekiguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayasu Sekiguchi. Masayasu Sekiguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 26
2 17
3 27
4 8
5 38
6 61
7 51
8 128

About Masayasu Sekiguchi

Masayasu Sekiguchi is a scholar working on Equine, Pharmacology and Small Animals, having authored 8 papers that have together received 356 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Orthopedic Infections and Treatments (3 papers) and bioluminescence and chemiluminescence research (2 papers). The work is most often cited by research in Pharmacology (167 citations), Toxicology (21 citations) and Molecular Medicine (27 citations). Masayasu Sekiguchi has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Y Osada, T Une, Kazuhisa Furuhama, Shinsaku Sakurada, Noriko Tanaka, S. Zaki Salahuddin, Richard L. Gallo, Shuji Nakamura, Toshimasa Jindo and Kōichi Goto. Their work appears in journals such as Science, Antimicrobial Agents and Chemotherapy and Toxicology Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026